The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Developments in AI for lung caner screening
Daniel Miller, MD, Medical College of Georgia, Augusta, GA, gives an overview of the emerging role of artificial intelligence (AI) in assessing the presence of lung cancer in interpulmonary nodules. The high accuracy reduces the number of unnecessary biopsies, and patients are often curious about the novelty of this technology. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
